Truvestments Capital’s Sanofi SNY Stock Holding History

Truvestments Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$70.4K	Buy	1,461 +59	+4%	+$2.75K	0.01%	451
2025 Q4	$67.9K	Hold	1,402	–	–	0.01%	403
2025 Q3	$66.2K	Buy	1,402 +19	+1%	+$917	0.01%	403
2025 Q2	$66.8K	Sell	1,383 -230	-14%	-$11.8K	0.01%	348
2025 Q1	$89.5K	Buy	+1,613	New	+$87.3K	0.02%	309
2022 Q3	–	Sell	-219	Closed	-$11K	–	658
2022 Q2	$11K	Buy	+219	New	+$11.6K	0.01%	405
2022 Q1	–	Sell	-461	Closed	-$23K	–	490
2021 Q4	$23K	Hold	461	–	–	0.01%	333
2021 Q3	$22K	Hold	461	–	–	0.01%	313
2021 Q2	$24K	Buy	461 +1	+0.2%	+$52	0.01%	310
2021 Q1	$23K	Hold	460	–	–	0.01%	360
2020 Q4	$22K	Buy	+460	New	+$22.7K	0.02%	353
2020 Q3	–	Sell	-527	Closed	-$26K	–	520
2020 Q2	$26K	Buy	527 +11	+2%	+$535	0.03%	276
2020 Q1	$22K	Buy	+516	New	+$24.7K	0.03%	257
2019 Q4	–	Sell	-1,091	Closed	-$51K	–	515
2019 Q3	$51K	Hold	1,091	–	–	0.03%	262
2019 Q2	$47K	Sell	1,091 -24	-2%	-$1.02K	0.03%	295
2019 Q1	$49K	Buy	+1,115	New	+$47.8K	0.04%	278
2018 Q3	$53K	Buy	+1,175	New	+$50.2K	0.03%	376

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Truvestments Capital's SNY Position: Q1 2026 in Review

Truvestments Capital increased its Sanofi (SNY) stake by 4.2% in Q1 2026, buying an estimated $2.75K and bringing the position to 1,461 shares worth $70.4K. The position accounts for 0.01% of the portfolio, ranked #451.

Truvestments Capital first reported a position in SNY in Q3 2018 and has held it in 17 quarters since. The position peaked at $89.5K in Q1 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Truvestments Capital held 1,461 shares of Sanofi worth $70.4K as of Q1 2026.
Truvestments Capital bought 59 Sanofi shares in Q1 2026, an estimated $2.75K.
Sanofi made up 0.01% of Truvestments Capital's portfolio in Q1 2026, its #451 holding.
Truvestments Capital first reported a position in Sanofi in Q3 2018 and has held it in 17 quarters since.
Truvestments Capital's Sanofi position peaked at $89.5K in Q1 2025.
737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.